Table 1.
End-point | Boceprevir | Telaprevir |
RGT | Non-cirrhotic treatment naïve patients, previously relapsers or partial responders | Non-cirrhotic treatment naïve patients previously relapsers |
HCV-RNA undetectable at weeks 8 and 24 | HCV-RNA undetectable at weeks 4 and 24 | |
Futility rules | HCV-RNA > 100 IU/mL at week 12 | HCV-RNA > 1000 IU/mL at weeks 4 and 12 |
HCV-RNA detectable at week 24 | HCV-RNA detectable at week 24 |
HCV: Hepatitis C virus.